Press Release
Global Biopharmaceuticals Market is Estimated to Reach $405 Billion by 2024, Says Variant Market Research
 Published Date:  Aug 2017  Publish By: Variant Market Research

Global Biopharmaceutical Market Report, published by Variant Market Research, forecast that the global market is expected to reach $405 Billion by 2024 from $200 Billion in 2016, growing at a CAGR of 9.3% from 2016 to 2024. By geography, Asia-Pacific and North America are expected to grow at a CAGR of 11.4% and 9.0%, respectively, during the forecast period.

"Biopharmaceuticals Market (Monoclonal Antibodies, Recombinant Proteins, Granulocyte Colony-Stimulating Factor, Interferon, Recombinant Human Insulin, Erythropoietin, Vaccines, Growth Hormones, Purified Proteins; Oncology, Inflammatory Infectious Diseases, Metabolic Disorders, Cardiovascular Diseases; North America, Europe, Asia-Pacific, and RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024"

To browse the complete report, visit at: https://www.variantmarketresearch.com/report-categories/pharmaceuticals/biopharmaceuticals-market

Some of the factors driving the growth of the global biopharmaceuticals market include technological advancements, enhanced proficiency over conventional drugs, and occurrence of autoimmune diseases and cancers. Though, entry of low priced biosimilars and risk of adverse effects could pose challenge for the market, Additionally, rising R&D, rising government initiatives for developing effective products, and popularity of herbal medicines worldwide provide opportunities in the forecast years.

Type, therapeutic application, and geography are the key bifurcations considered in the global biopharmaceutical market. By type, it is segmented into monoclonal antibodies, recombinant proteins, granulocyte colony-stimulating factor (G-CSF), interferon, recombinant human insulin, erythropoietin, vaccines, growth hormones, purified proteins, and others. Among which, recombinant proteins are expected to dominate with largest market share and fastest CAGR. Therapeutic application is further bifurcated into oncology, inflammatory infectious diseases, metabolic disorders, cardiovascular diseases, and others. Others and oncology accounted the majority of the share in 2016.

Geographically, the biopharmaceuticals market has been bifurcated into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America held the largest market share of 39.9% in 2016, driven by increasing number of R&D, product launch, and outsourcing the manufacturing process, followed by Europe with share of 34.7%. In terms of growth, Asia-Pacific is anticipated to attain the fastest CAGR during the forecast period, driven by adoption of advanced technologies, increasing investments in R&D, and increasing partnerships with major companies for contract manufacturing.

Major companies operating in the global biopharmaceuticals market include Roche Holding AG, Bayer AG, Abbott Laboratories, Biocon Ltd, Eli Lilly and Company, Ranbaxy Laboratories Ltd., Pfizer Inc., Novartis AG, Genentech, Inc., and Johnson & Johnson, Inc, among others.

Contact Us:

John Dave,
Head - Sales 
Variant Market Research
649 Mission St, 5th Floor, San Francisco, CA 94105, United States.
Tel: +1-415-680-2785
Fax: +1-415-680-2786
Email: john.dave@variantmarketresearch.com 
Email: help@variantmarketresearch.com


GET MORE INFORMATION ABOUT THIS REPORT


Refresh Captcha

Chapter 1 Prefix
    1.1 Market Scope
    1.2 Report Description
    1.3 Research Methodology
          1.3.1 Primary Research
          1.3.2 Secondary Research
          1.3.3 In-house Data Modeling
Chapter 2 Executive Summary
Chapter 3 Market Outline
    3.1 Market Inclination, Trend, Outlook and Viewpoint
    3.2 Market Share Analysis: Company’s Competitive Scenario
    3.3 Market Dynamics
          3.3.1 Drivers
                   3.3.1.1 Impact Analysis
          3.3.2 Restraints
                   3.3.2.1 Impact Analysis
          3.3.3 Opportunities
Chapter 4 Biopharmaceuticals Market by Type: Market Size and Forecast, 2015 – 2024
    4.1 Overview
    4.2 Monoclonal Antibodies
          4.2.1 Current Trend and Analysis
          4.2.2 Market Size and Forecast
    4.3 Recombinant Proteins
          4.3.1 Current Trend and Analysis
          4.3.2 Market Size and Forecast
    4.4 Granulocyte Colony-Stimulating Factor (G-CSF)
          4.4.1 Current Trend and Analysis
          4.4.2 Market Size and Forecast
    4.5 Interferon
          4.5.1 Current Trend and Analysis
          4.5.2 Market Size and Forecast
    4.6 Recombinant Human Insulin
          4.6.1 Current Trend and Analysis
          4.6.2 Market Size and Forecast
    4.7 Erythropoietin
          4.7.1 Current Trend and Analysis
          4.7.2 Market Size and Forecast
    4.8 Vaccines
          4.8.1 Current Trend and Analysis
          4.8.2 Market Size and Forecast
    4.9 Growth Hormones
          4.9.1 Current Trend and Analysis
          4.9.2 Market Size and Forecast
    4.10 Purified Proteins
          4.10.1 Current Trend and Analysis
          4.10.2 Market Size and Forecast
    4.11 Other Types
          4.11.1 Current Trend and Analysis
          4.11.2 Market Size and Forecast
Chapter 5 Biopharmaceuticals Market by Therapeutic Application: Market Size and Forecast, 2015 – 2024
    5.1 Overview
    5.2 Oncology
          5.2.1 Current Trend and Analysis
          5.2.2 Market Size and Forecast
    5.3 Inflammatory Infectious Diseases
          5.3.1 Current Trend and Analysis
          5.3.2 Market Size and Forecast
    5.4 Metabolic Disorders
          5.4.1 Current Trend and Analysis
          5.4.2 Market Size and Forecast
    5.5 Cardiovascular Diseases
          5.5.1 Current Trend and Analysis
          5.5.2 Market Size and Forecast
    5.6 Other Therapeutic Applications
          5.6.1 Current Trend and Analysis
          5.6.2 Market Size and Forecast
Chapter 6 E-Clinical Solution Software Market by Geography: Market Size and Forecast, 2015 – 2024
    6.1 Overview
    6.2 North America
          6.2.1 Current Trend and Analysis
          6.2.2 Market Size and Forecast
          6.2.3 US
                   6.2.3.1 Market Size and Forecast
          6.2.4 Canada
                   6.2.4.1 Market Size and Forecast
          6.2.5 Mexico
                   6.2.5.1 Market Size and Forecast
    6.3 Europe
          6.3.1 Current Trend and Analysis
          6.3.2 Market Size and Forecast
          6.3.3 UK
                   6.3.3.1 Market Size and Forecast
          6.3.4 Germany
                   6.3.4.1 Market Size and Forecast
          6.3.5 France
                   6.3.5.1 Market Size and Forecast
          6.3.6 Italy
                   6.3.6.1 Market Size and Forecast
          6.3.6 Others
                   6.3.6.1 Market Size and Forecast
    6.4 Asia-Pacific
          6.4.1 Current Trend and Analysis
          6.4.2 Market Size and Forecast
          6.4.3 Japan
                   6.4.3.1 Market Size and Forecast
          6.4.4 China
                   6.4.4.1 Market Size and Forecast
          6.4.5 India
                   6.4.5.1 Market Size and Forecast
          6.4.6 Others
                   6.4.6.1 Market Size and Forecast
    6.5 RoW
          6.5.1 Current Trend and Analysis
          6.5.2 Market Size and Forecast
          6.5.3 Middle East
                   6.5.3.1 Market Size and Forecast
          6.5.4 South America
                   6.5.4.1 Market Size and Forecast
          6.5.5 Africa
                   6.5.5.1 Market Size and Forecast
Chapter 7 Company Profiles
    7.1 Roche Holding AG
    7.2 Bayer AG
    7.3 Abbott Laboratories
    7.4 Biocon Ltd
    7.5 Eli Lilly and Company
    7.6 Ranbaxy Laboratories Ltd.
    7.7 Pfizer Inc.
    7.8 Novartis AG
    7.9 Genentech, Inc.
    7.10 Johnson & Johnson, Inc

GET MORE INFORMATION ABOUT THIS REPORT


Refresh Captcha

Please fill the form below and our research expert will get in touch with you.


Refresh Captcha

Please fill the form below and our research expert will get in touch with you.


Refresh Captcha